95 related articles for article (PubMed ID: 24825746)
1. Biology of breast cancer during pregnancy using genomic profiling.
Azim HA; Brohée S; Peccatori FA; Desmedt C; Loi S; Lambrechts D; Dell'Orto P; Majjaj S; Jose V; Rotmensz N; Ignatiadis M; Pruneri G; Piccart M; Viale G; Sotiriou C
Endocr Relat Cancer; 2014 Aug; 21(4):545-54. PubMed ID: 24825746
[TBL] [Abstract][Full Text] [Related]
2. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL
J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148
[TBL] [Abstract][Full Text] [Related]
3. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
[TBL] [Abstract][Full Text] [Related]
4. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.
Azim HA; Michiels S; Bedard PL; Singhal SK; Criscitiello C; Ignatiadis M; Haibe-Kains B; Piccart MJ; Sotiriou C; Loi S
Clin Cancer Res; 2012 Mar; 18(5):1341-51. PubMed ID: 22261811
[TBL] [Abstract][Full Text] [Related]
5. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.
Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Paish EC; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2010 Jul; 122(1):45-53. PubMed ID: 19701705
[TBL] [Abstract][Full Text] [Related]
8. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
9. Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.
Al-Mulla F; Marafie M; Zea Tan T; Paul Thiery J
J Cell Biochem; 2014 Mar; 115(3):488-97. PubMed ID: 24123286
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
11. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
12. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
[TBL] [Abstract][Full Text] [Related]
13. Genomic subtypes in choosing adjuvant therapy for breast cancer.
Zelnak AB; O'Regan RM
Oncology (Williston Park); 2013 Mar; 27(3):204-10. PubMed ID: 23687790
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes.
Cuadros M; Cano C; López FJ; López-Castro R; Concha A
Pathobiology; 2013; 80(1):32-40. PubMed ID: 22832278
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.
Azim HA; Santoro L; Russell-Edu W; Pentheroudakis G; Pavlidis N; Peccatori FA
Cancer Treat Rev; 2012 Nov; 38(7):834-42. PubMed ID: 22785217
[TBL] [Abstract][Full Text] [Related]
17. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
[TBL] [Abstract][Full Text] [Related]
18. Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer.
Nguyen B; Venet D; Lambertini M; Desmedt C; Salgado R; Horlings HM; Rothé F; Sotiriou C
Breast Cancer Res; 2019 Feb; 21(1):25. PubMed ID: 30770770
[TBL] [Abstract][Full Text] [Related]
19. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
[TBL] [Abstract][Full Text] [Related]
20. ROCK: a breast cancer functional genomics resource.
Sims D; Bursteinas B; Gao Q; Jain E; MacKay A; Mitsopoulos C; Zvelebil M
Breast Cancer Res Treat; 2010 Nov; 124(2):567-72. PubMed ID: 20563840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
